NHC Comments on Information Collection Request for Drug Price Negotiation by IRA
Putting Patients First Blog
MAY 22, 2023
Driven by the work of the Food and Drug Administration on patient-focused drug development (PFDD), many companies in the biopharmaceutical community have devoted significant resources to better understand patient populations and are working to bring to market products that best suit their needs.
Let's personalize your content